Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Ovarian Cancer Recurrent
×
Carboplatin
×
Clear all
Filters
3
NCT06843447
2026-03-27
MK-5909-003
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
280 enrolled
NCT01332656
2015-12-21
OPSALIN
Sanofi
Phase 2
Completed
154 enrolled